1-1 of 1
Miray Cimist
Close
Sort by
Journal Articles

Long Term Responses to Rigosertib in Lower-Risk Myelodysplastic Syndromes (MDS) Patients

Azra Raza, MD, Can Yalçın, Miray Cimist, Ryan Shelton, BS, Syed Fazl Ali Bilgrami, MD, Mark Lawrence Heaney, MD PhD, Abdullah Mahmood Ali, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 5316.
https://doi.org/10.1182/blood.V130.Suppl_1.5316.5316
Published: 2017